Hodgkin lymphoma in patient with primary immunodeficiency: clinical features and treatment approaches

نویسندگان

چکیده

Primary immunodeficiencies (PID) are genetically determined irreversible disorders of structure and/or functions the immune system's cellular and humoral components, accompanied by frequent infectious diseases contributing to development malignant neoplasms. Lymphomas most oncological disease in PID patients: non-Hodgkin's lymphomas occur 60 % neoplasms cases, Hodgkin lymphoma - 20 %, leukemias 10 solid tumors %. The risk lymphoproliferative patients amounts 4-25 with overall incidence cancer 100-200 times higher than immunocompetent population. Results treatment children remain unsatisfactory due high rate relapsed, refractory anticancer therapy complications. This paper presents a clinical case atypical localization female patient. peculiarities this eye socket soft tissue involvement, slow response therapy,

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Primary Hepatic Burkitt’s Lymphoma in a Patient With Acquired Immunodeficiency Syndrome

  Primary non-Hodgkin lymphoma of liver is a very rare malignancy. Here we report a case of primary hepatic Burkitt’s lymphoma in a 34-year old man who was known case of acquired immunodeficiency syndrome (AIDS) and presented with weight loss, abdominal pain, and fever. Positive laboratory findings were mild anemia and elevated levels of lactate dehydrogenase (LDH) and alkaline phosphatase (AL...

متن کامل

Diagnosis and Treatment B non-Hodgkin Lymphoma with System Biology Approaches

Lymphomas are solid tumors of immune system and Non-Hodgkin Lymphomas (NHL) is the most prevalent lymphomas; with wide ranges of histological and clinical features, it is so difficult to identify them. Herein, various bioinformatics tools (such as gene differential expressions, epigenetics and protein analysis) employed to find new treatment approach for NHL based on gene expression variation b...

متن کامل

Evolving approaches to primary treatment of Hodgkin lymphoma.

Two challenges confront the clinician treating Hodgkin lymphoma today: achieving a high level of effectiveness while minimizing toxicity. At least 80% of patients can be cured with currently available chemotherapy regimens, augmented in selected patients with the addition of involved field radiation or intensified chemotherapy assisted by granulocyte growth factors or stem cell transplantation....

متن کامل

Treatment of Newly Diagnosed and Relapsed Hodgkin Lymphoma in Children

Hodgkin lymphoma (HL) accounts for about 10% of all childhood cancers. Five-year survival rates with modern therapies are now approaching >90-95% as a consequence of its significant sensitivity to both chemotherapy and radiation. The current challenge is to determine how much therapy is needed to improve survival and how to adapt treatment to the patient to prevent these long term toxicities. T...

متن کامل

Human immunodeficiency and Hodgkin lymphoma.

Presentation of Hodgkin lymphoma (HL) is distinctive in the infected individual being more advanced, accompanied by B symptoms and the presence of extranodal disease particularly lymphadenopathy of the head and neck. Bone marrow involvement may be found in over 50% of cases. Virtually all co express gamma-herpesvirus. Phenotypically there is prominence of the mixed-cellularity and lymphocyte de...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: ???????????????

سال: 2022

ISSN: ['2508-9099', '2672-1198']

DOI: https://doi.org/10.17650/1818-8346-2022-17-3-73-82